On February 22, 2022, a new regulation kicked into effect in the EU for infant formulas and follow-on formulas containing protein hydrolysates, requiring companies to submit dossiers on their ingredients so that EFSA can evaluate their safety and suitability for use in these products.
The European Food Safety Authority (EFSA) published a positive opinion acknowledging that Arla Foods Ingredients’ Peptigen IF-3080 protein hydrolysate ingredient is safe for use in infant formulas and follow-on formulas in the EU.
On February 22, 2022, a new regulation kicked into effect in the EU for infant formulas and follow-on formulas containing protein hydrolysates, requiring companies to submit dossiers on their ingredients so that EFSA can evaluate their safety and suitability for use in these products. Ingredients not approved cannot be sold in the market in these products.
Arla Foods Ingredients’ Peptigen IF-3080 is “one of only a few milk protein hydrolysate ingredients to receive a positive EFSA opinion to date,” the company stated in a March 2022 press release.
“We are delighted by this opinion, which supports our reputation for having the industry’s highest levels of quality, innovation, and food safety,” stated Anders Steen Jørgensen, head of SBU Pediatric, Arla Foods Ingredients, in the press release.
Magnesium L-threonate, Magtein, earns novel food authorization in the European Union
December 19th 2024According to the announcement, the authorization is also exclusive to AIDP and its partner company and licensee, ThreoTech, meaning that they are the only parties that can market magnesium L-threonate in the EU for a period of five years.
Survey finds a lack of enthusiasm about AI technology among food and beverage consumers
December 12th 2024The survey, commissioned by Ingredient Communications and conducted by SurveyGoo, found that 83% of respondent agreed that companies should declare on product labels when a product has been designed or manufactured with the assistance of AI technology.